India
oi-Deepika S
New Delhi, Aug 11: The Drugs Controller General Of India (DCGI) on Wednesday gave nod to a study on mixing Covishield and Covaxin, the two main vaccines used in India’s COVID-19 vaccination programme.
“Permission has been granted for a research study by CMC Vellore (Tamil Nadu) on mixing of vaccines doses, said Dr V K Paul, Niti Aayog.
The mixing and matching of two COVID vaccines -Covaxin and Covishield – shows better result, revealed a study conducted by (ICMR).
“Immunisation with combination of an adenovirus vector platform-based vaccine followed by inactivated whole virus vaccine was not only safe but also elicited better immunogenicity,” the study said.
“To the best of our knowledge, this is the first study which reports the effects of heterologous prime-boost vaccination with an adenovirus vectored vaccine followed by an inactivated whole virus…
